Successful use of oseltamivir prophylaxis in managing a nosocomial outbreak of influenza A in a hematology and allogeneic stem cell transplant unit

Asia-Pacific Journal of Clinical Oncology

Volumn 13, Issue 1, 2017, Pages 37-43

  Yue, Mimi C ^a,b   Collins, Joel T ^a,b   Subramoniapillai, Elango ^a   Kennedy, Glen A ^a,b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

H1N1; hematology; hematopoietic stem cell transplant; influenza A; oseltamivir

Indexed keywords

OSELTAMIVIR; ANTIVIRUS AGENT;

ADULT; ARTICLE; AUSTRALIA; CANCER PREVENTION; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDEMIC; FOLLOW UP; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INFECTION CONTROL; INFLUENZA A; INFLUENZA A VIRUS (H1N1); INTENSIVE CARE; LUNG LAVAGE; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; SYMPTOM; THROAT CULTURE; VIRUS STRAIN; WINTER; ADOLESCENT; ADVERSE EFFECTS; CROSS INFECTION; DISEASE OUTBREAKS; DRUG EFFECTS; FEMALE; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; INFLUENZA, HUMAN; PROCEDURES; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CROSS INFECTION; DISEASE OUTBREAKS; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INFECTION CONTROL; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; OSELTAMIVIR; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION;

EID: 84995403693     PISSN: 17437555     EISSN: 17437563     Source Type: Journal    
DOI: 10.1111/ajco.12565     Document Type: Article

References (40)

1. Gooskens J, Jonges M, Claas ECJ, Meijer A, Kroes ACM. Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses. J Infect Dis 2009; 199 (10): 1435–41.
2. Klimov AI, Rocha E, Hayden FG, Shult PA, Roumillat LF, Cox NJ. Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis. J Infect Dis 1995; 172 (5): 1352–5.
3. Weinstock DM, Gubareva LV, Zuccotti G. Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient. N Engl J Med 2003; 348 (9): 867–8.
4. Choi SM, Boudreault AA, Xie H, Englund JA, Corey L, Boeckh M. Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients. Blood 2011; 117 (19): 5050–6.
5. Dignani MC, Costantini P, Salgueira C et al. Pandemic 2009 influenza A (H1N1) virus infection in cancer and hematopoietic stem cell transplant recipients; a multicenter observational study. F1000Res 2014; 3: 221–232.
6. Liu C, Schwartz BS, Vallabhaneni S et al. Pandemic (H1N1) 2009 infection in patients with hematologic malignancy. Emerg Infect Dis 2010; 16 (12): 1910–7.
7. Ljungman P, de la Camara R, Perez-Bercoff L et al. Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients. Haematologica 2011; 96 (8): 1231–5.
8. Mohty B, Thomas Y, Vukicevic M et al. Clinical features and outcome of 2009-influenza A (H1N1) after allogeneic hematopoietic SCT. Bone Marrow Transplant 2012; 47 (2): 236–42.
9. Wei JY, Chen FF, Jin J et al. Novel influenza A (H1N1) in patients with hematologic disease. Leuk Lymphoma 2010; 51 (11): 2079–83.
10. Chen LF, Dailey NJ, Rao AK et al. Cluster of oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infections on a hospital ward among immunocompromised patients—North Carolina, 2009. J Infect Dis 2011; 203 (6): 838–46.
11. George B, Ferguson P, Kerridge I, Gilroy N, Gottlieb D, Hertzberg M. The clinical impact of infection with swine flu (H1N109) strain of influenza virus in hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 2011; 17 (1): 147–53.
12. Pollara CP, Piccinelli G, Rossi G et al. Nosocomial outbreak of the pandemic Influenza A (H1N1) 2009 in critical hematologic patients during seasonal influenza 2010-2011: detection of oseltamivir resistant variant viruses. BMC Infect Dis 2013; 13: 127–33.
13. Tramontana AR, George B, Hurt AC et al. Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia. Emerg Infect Dis 2010; 16 (7): 1068–75.
14. Caselli D, Carraro F, Castagnola E et al. Morbidity of pandemic H1N1 influenza in children with cancer. Pediatr Blood Cancer 2010; 55 (2): 226–8.
15. Cost C, Brock E, Adams-Huet B, Siegel JD, Ardura MI. 2009 pandemic influenza A (H1N1) virus infection in pediatric oncology and hematopoietic stem cell transplantation patients. Pediatr Blood Cancer2011; 56 (1): 127–33.
16. Karapinar DY, Ay Y, Karzaoglu Z et al. Experience of pandemic influenza with H1N1 in children with leukemia. Pediatr Hematol Oncol 2011; 28 (1): 31–6.
17. Launes C, Rives S, Catala A et al. Pandemic influenza A (2009 H1N1) in children with acute lymphoblastic leukaemia. Br J Haematol 2010; 149: 874–8.
18. Tran D, Science M, Dix D et al. Pandemic (H1N1) 2009 influenza in Canadian pediatric cancer and hematopoietic stem cell transplant patients. Influenza Other Respir Viruses 2012; 6 (6): e105–13.
19. Dobson J, Whitley RJ, Pocock S, Monto AS. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet 2015; 385 (9979): 1729–37.
20. Jefferson T, Jones MA, Doshi P et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev 2014; 4: doi: 10.1002/14651858.CD008965.pub4.
21. Australian Influenza Surveillance Report No. 8. Australian Government Department of Health website 2014 [Cited 20 Sept 2015.] Available from http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-ozflu-flucurr.htm.
22. Redelman-Sidi G, Sepkowitz K, Huang C, Park S, Stiles J, Eagan J. H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients. J Infect 2009; 60 (4): 257–63.
23. Lalayanni C, Sirigou A, Iskas M, Smias C, Sakellari I, Anagnostopoulos A. Outbreak of novel influenza A (H1N1) in an adult haematology department and haematopoietic cell transplantation unit: clinical presentation and outcome. J Infect 2010; 61 (3): 270–2.
24. Iioka F, Sada R, Maesako Y, Nakamura F, Ohno H. Outbreak of pandemic 2009 influenza A/H1N1 infection in the hematology ward: fatal clinical outcome of hematopoietic stem cell transplant recipients and emergence of the H275Y neuraminidase mutation. Int J Hematol 2012; 96 (3): 364–9.
25. Rihani R, Hayajneh W, Sultan I et al. Infections with the 2009 H1N1 influenza virus among hematopoietic SCT recipients: a single center experience. Bone Marrow Transplant 2011; 46: 1430–6.
26. Nichols WG, Guthrie KA, Corey L, Boeckh M. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004; 39: 1300–6.
27. Couturier BA, Bender JM, Schwarz MA, Pavia AT, Hanson KE, She RC. Oseltamivir-resistant influenza A 2009 H1N1 virus in immunocompromised patients. Influenza Other Respir Viruses 2010; 4: 199–204.
28. Wolfe C, Greenwald I, Chen L. Pandemic (H1N1) 2009 and oseltamivir resistance in hematology/oncology patients. Emerg Infect Dis 2010; 16 (11): 1809–11.
29. Yoneda M, Okayama A, Kitahori Y. Oseltamivir-resistant seasonal A(H1N1) and A(H1N1)pdm09 influenza viruses from the 2007/2008 to 2012/2013 season in Nara Prefecture, Japan. Jpn J Infect Dis 2014; 67: 385–8.
30. Bearden A, Friedrich TC, Goldberg TL et al. An outbreak of the 2009 influenza a (H1N1) virus in a children's hospital. Influenza Other Respir Viruses 2012; 6 (5): 374–9.
31. Buchbinder N, Dumesnil C, Pinquier D et al. Pandemic A/H1N1/2009 influenza in a paediatric haematology and oncology unit: successful management of a sudden outbreak. J Hosp Infect 2011; 79 (2): 155–60.
32. Vu D, Peck AJ, Nichols WG et al. Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control study. Clin Infect Dis 2007; 45 (2): 187–93.
33. Ison MG, Szakaly P, Shapira MY, Kriván G, Nist A, Dutkowski R. Efficacy and safety of oral oseltamivir for influenza prophylaxis in transplant recipients. Antivir Ther 2012; 17 (6): 955–64.
34. Lalayanni C, Sirigou A, Iskas M, Smias C, Sakellari I, Anagnostopoulos A. Outbreak of novel influenza A (H1N1) in an adult haematology department and haematopoietic cell transplantation unit: clinical presentation and outcome. J Infect 2010; 61 (3): 270–2.
35. Anekthananon T, Pukrittayakamee S, Pukritayakamee S et al. Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks. J Antimicrob Chemother 2013; 68 (3): 697–707.
36. Upjohn LM, Stewardson AJ, Marshall C. Oseltamivir adherence and tolerability in health care workers treated prophylactically after occupational influenza exposure. Am J Infect Control 2012; 40 (10): 1020–2.
37. Stuart RL, Cheng AC, Marshall CL, Ferguson JK; Healthcare infection control special interest group of the Australian Society for Infectious Diseases. ASID (HICSIG) position statement: infection control guidelines for patients with influenza-like illnesses, including pandemic (H1N1) influenza 2009, in Australian health care facilities. Med J Aust 2009; 191 (8): 454–8.
38. Cheng AC, Dwyer DE, Kotsimbos AT et al. Summary of the Australasian Society for Infectious Diseases and the Thoracic Society of Australia and New Zealand guidelines: treatment and prevention of H1N1 influenza 09 (human swine influenza) with antiviral agents. Med J Aust 2009; 191 (3): 142–5.
39. Harper SA, Bradley JS, Englund JA et al. Seasonal influenza in adults and children—diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009; 48 (8): 1003–32.
40. Engelhard D, Mohty B, de la Camara R, Cordonnier C, Ljungman P. European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN. Transpl Infect Dis 2013; 15 (3): 219–32.